Literature DB >> 22520629

A highly selective Hsp90 affinity chromatography resin with a cleavable linker.

Philip F Hughes1, Jared J Barrott, David A Carlson, David R Loiselle, Brittany L Speer, Khaldon Bodoor, Lauretta A Rund, Timothy A J Haystead.   

Abstract

Over 200 proteins have been identified that interact with the protein chaperone Hsp90, a recognized therapeutic target thought to participate in non-oncogene addiction in a variety of human cancers. However, defining Hsp90 clients is challenging because interactions between Hsp90 and its physiologically relevant targets involve low affinity binding and are thought to be transient. Using a chemo-proteomic strategy, we have developed a novel orthogonally cleavable Hsp90 affinity resin that allows purification of the native protein and is quite selective for Hsp90 over its immediate family members, GRP94 and TRAP 1. We show that the resin can be used under low stringency conditions for the rapid, unambiguous capture of native Hsp90 in complex with a native client. We also show that the choice of linker used to tether the ligand to the insoluble support can have a dramatic effect on the selectivity of the affinity media.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22520629      PMCID: PMC3345094          DOI: 10.1016/j.bmc.2012.03.043

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  42 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

Authors:  Kamalika Moulick; James H Ahn; Hongliang Zong; Anna Rodina; Leandro Cerchietti; Erica M Gomes DaGama; Eloisi Caldas-Lopes; Kristin Beebe; Fabiana Perna; Katerina Hatzi; Ly P Vu; Xinyang Zhao; Danuta Zatorska; Tony Taldone; Peter Smith-Jones; Mary Alpaugh; Steven S Gross; Nagavarakishore Pillarsetty; Thomas Ku; Jason S Lewis; Steven M Larson; Ross Levine; Hediye Erdjument-Bromage; Monica L Guzman; Stephen D Nimer; Ari Melnick; Len Neckers; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

3.  Comparative analysis of cleavable azobenzene-based affinity tags for bioorthogonal chemical proteomics.

Authors:  Yu-Ying Yang; Markus Grammel; Anuradha S Raghavan; Guillaume Charron; Howard C Hang
Journal:  Chem Biol       Date:  2010-11-24

Review 4.  Development and application of Hsp90 inhibitors.

Authors:  David B Solit; Gabriela Chiosis
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

5.  Heat shock protein 90: inhibitors in clinical trials.

Authors:  Marco A Biamonte; Ryan Van de Water; Joseph W Arndt; Robert H Scannevin; Daniel Perret; Wen-Cherng Lee
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

6.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

Review 7.  Design, synthesis, and evaluation of small molecule Hsp90 probes.

Authors:  Tony Taldone; Danuta Zatorska; Pallav D Patel; Hongliang Zong; Anna Rodina; James H Ahn; Kamalika Moulick; Monica L Guzman; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2011-03-12       Impact factor: 3.641

8.  Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.

Authors:  T W Schulte; S Akinaga; T Murakata; T Agatsuma; S Sugimoto; H Nakano; Y S Lee; B B Simen; Y Argon; S Felts; D O Toft; L M Neckers; S V Sharma
Journal:  Mol Endocrinol       Date:  1999-09

9.  Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.

Authors:  Ami Citri; Judith Gan; Yaron Mosesson; Gyorgi Vereb; Janos Szollosi; Yosef Yarden
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

10.  Post-translational modification of heat-shock protein 90: impact on chaperone function.

Authors:  Bradley T Scroggins; Len Neckers
Journal:  Expert Opin Drug Discov       Date:  2007-10       Impact factor: 6.098

View more
  14 in total

1.  An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.

Authors:  Matthew K Howe; Brittany L Speer; Philip F Hughes; David R Loiselle; Subhash Vasudevan; Timothy A J Haystead
Journal:  Antiviral Res       Date:  2016-04-04       Impact factor: 5.970

Review 2.  Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development.

Authors:  Len Neckers; Brian Blagg; Timothy Haystead; Jane B Trepel; Luke Whitesell; Didier Picard
Journal:  Cell Stress Chaperones       Date:  2018-02-01       Impact factor: 3.667

3.  A Human Variant of Glucose-Regulated Protein 94 That Inefficiently Supports IGF Production.

Authors:  Michal Marzec; Colin P Hawkes; Davide Eletto; Sarah Boyle; Ron Rosenfeld; Vivian Hwa; Jan M Wit; Hermine A van Duyvenvoorde; Wilma Oostdijk; Monique Losekoot; Oluf Pedersen; Bu Beng Yeap; Leon Flicker; Nir Barzilai; Gil Atzmon; Adda Grimberg; Yair Argon
Journal:  Endocrinology       Date:  2016-03-16       Impact factor: 4.736

Review 4.  Affinity-based profiling of endogenous phosphoprotein phosphatases by mass spectrometry.

Authors:  Brooke L Brauer; Kwame Wiredu; Sierra Mitchell; Greg B Moorhead; Scott A Gerber; Arminja N Kettenbach
Journal:  Nat Protoc       Date:  2021-09-13       Impact factor: 13.491

5.  Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain.

Authors:  Yaomin Wang; Scott A Scarneo; Shin Hyung Kim; Xin Zhang; Jiegen Chen; Kelly W Yang; Philip Hughes; Timothy Haystead; Andrea G Nackley
Journal:  Pain       Date:  2021-10-12       Impact factor: 7.926

Review 6.  Hsp90, an unlikely ally in the war on cancer.

Authors:  Jared J Barrott; Timothy A J Haystead
Journal:  FEBS J       Date:  2013-02-24       Impact factor: 5.542

7.  Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.

Authors:  Jared J Barrott; Philip F Hughes; Takuya Osada; Xiao-Yi Yang; Zachary C Hartman; David R Loiselle; Neil L Spector; Len Neckers; Narasimhan Rajaram; Fangyao Hu; Nimmi Ramanujam; Ganesan Vaidyanathan; Michael R Zalutsky; H Kim Lyerly; Timothy A Haystead
Journal:  Chem Biol       Date:  2013-09-12

8.  FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.

Authors:  Wei Huang; Min Ye; Lian-Ru Zhang; Qun-Dan Wu; Min Zhang; Jian-Hua Xu; Wei Zheng
Journal:  Mol Cancer       Date:  2014-06-14       Impact factor: 27.401

9.  Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes.

Authors:  Tony Taldone; Anna Rodina; Erica M DaGama Gomes; Matthew Riolo; Hardik J Patel; Raul Alonso-Sabadell; Danuta Zatorska; Maulik R Patel; Sarah Kishinevsky; Gabriela Chiosis
Journal:  Beilstein J Org Chem       Date:  2013-03-15       Impact factor: 2.883

10.  OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation.

Authors:  Devin Dersh; Stephanie M Jones; Davide Eletto; John C Christianson; Yair Argon
Journal:  Mol Biol Cell       Date:  2014-06-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.